London cannabis medicine firm lands multi-million pound investment to expand operations

A London cannabis medicine company has raised over £3.4m in Europe’s largest ever medical cannabis crowdfund.

Grow, which was founded in 2017, will use the investment to expand its operations in the UK and Europe, support its R&D programmes and increase its headcount.

Significant growth is expected in the medical cannabis sector in the coming years, with medicines prescribed for symptoms related to health issues such as epilepsy, insomnia and chronic pain. Cannabis insights firm Brightfield Group tips the sector to be worth $3.1b by 2025, with Grow hoping to capitalise on that as a market leader in the UK.

The company recently announced the acquisition of Sanoid Isolates, a production facility in Andalusia, Spain, which allows for the production of cannabis in climates similar to those of California.

Ben Langley, CEO of Grow, said: “The success of our crowdfund shows just how much interest there is in the nascent industry, which I truly believe can have an enormous social impact.”

He continued: “So many have already signed up to join our community as socially conscious shareholders, and I would urge hundreds more to do the same. The more people who join our mission, the more we can work to improve the production, education and supply of cannabis medicines to help thousands more people who need it.”

Grow’s crowdfund is already the largest cannabis raise ever on Seedrs and will be open to investors until September 8th.

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →